Rucosopasem manganese

N/A

Report date: 2025/03/04 20:00:11
NME

Base Information

Drug NameRucosopasem manganese
Drug Alias NameRucosopasemGC-4711
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiossil IncGalera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A